Biosyngen Pte Ltd is a clinical-stage biotechnology company focusing on developing most advanced immune cell therapies for EB virus-related cancers.

Biosyngen has offices in both China and Singapore, but they were looking to target English speaking partners and investors with the option of a Chinese webpage.